Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Safety Extension in Vascular Dementia
NCT00188812Phase 3Completed
- Sponsor
- University Health Network
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of donepezil in vascular dementia, sponsored by University Health Network. Primary endpoint: Safety assessments at 1 year. Started May 2004; status: completed.
02
Drugs
donepezil
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT00188812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188812.